ScreenerHero
EXPRS2ExpreS2ion Biotech Holding AB (publ)
STO · SE · Healthcare · Biotechnology · expres2ionbio.com
1.385SEK-0.72%Mkt Cap: 1.31M $P/E: —

ExpreS2ion Biotech Holding AB (publ), a clinical-stage biotechnology company, develops protein-based immunotherapies and vaccines for oncology and infectious diseases in the Nordics and internationally. The company's lea…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5
ARWR
Arrowhead Pharmaceuticals, Inc.
$12.59BUSD

Key Statistics

Company
Market Cap1.31M $
Enterprise Value-1.50M $
Revenue (TTM)1.54M $
Gross Profit13.10K $
Net Income (TTM)-3.64M $
Revenue/Share0.4367 USD
Last Price1.385 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees19
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0008348262
Valuation
P/E (Trailing)—
P/E (Forward)-0.06
PEG—
EV/EBITDA0.37
EV/Revenue-0.97
P/S0.85
P/B0.19
EPS (TTM)-3.29
EPS (Forward)-22.39
52W Range
1.22061% of range1.490
52W High1.490 SEK
52W Low1.220 SEK
Profitability
Gross Margin3.75%
Oper. Margin-173.86%
EBITDA Margin-261.65%
Profit Margin-1041.43%
ROE-106.72%
ROA-58.50%
Growth
Revenue Growth132.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.91M $
CapEx (TTM)—
FCF Margin-235.79%
FCF Yield-277.64%
Net Debt-1.97M $
Net Debt/EBITDA0.49
Balance Sheet
Debt/Equity0.04
Current Ratio1.87
Quick Ratio1.42
Book Value/Sh7.484 SEK
Cash/Share6.187 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:40
Split DateOct 30, 2024
Analyst Consensus
Rating—
Target (Mean)6.000 SEK
Upside (mean)+333.2%
Target Range6.000 SEK – 6.000 SEK
# Analysts1
Ownership
Shares Out.9.88M
Float3.46M
Insiders0.11%
Institutions0.00%
Technical
SMA 501.451 (-4.6%)
SMA 2007.833 (-82.3%)
Beta2.17
S&P 52W Chg18.16%
Avg Vol (30d)289.91K
Avg Vol (10d)265.06K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—